An Australian stem cell and regenerative medicine company

ASX Announcements

18 Nov 2014 Appendix 3X-Dr John Chiplin
18 Nov 2014 Appendix 3Z-Howard Digby
18 Nov 2014 Cynata Board Changes Implemented
13 Nov 2014 Section 708A Notice
13 Nov 2014 Appendix 3B-Exercise of Listed Options
11 Nov 2014 Section 708A Notice
11 Nov 2014 Appendix 3B-Exercise of Listed Options
06 Nov 2014 Restricted Securities to be released from ASX Escrow
05 Nov 2014 Australian Patent for Core Cynata Technology
26 Oct 2014 BBY Initiates Cynata Research Coverage
22 Oct 2014 Cynata to Appoint Dr John Chiplin to Board of Directors
21 Oct 2014 Section 708A Notice
21 Oct 2014 Appendix 3B-Exercise of Listed Options
15 Oct 2014 Notice of Annual General Meeting & Proxy Form
25 Sep 2014 Section 708A Notice
25 Sep 2014 Appendix 3B - Exercise of Listed Options
17 Sep 2014 Cynata Announces Landmark Licensing Deal
10 Sep 2014 Appendix 3B-Issue of Unlisted Options
08 Sep 2014 Section 708A Notice
08 Sep 2014 Appendix 3B-Exercise of Listed Options
02 Sep 2014 Cynata Initiates European Regulatory Process
02 Sep 2014 Cynata Responds to Option Transaction Queries
27 Jul 2014 CYP Contracts UW to Advance Cymerus Product Development
13 Jul 2014 Contracts Leading CRO to Conduct Cymerus Preclinical Studies
10 Jun 2014 Cynata Announces Partnership Agreement
01 Jun 2014 Leading Brokerage Initiates Cynata Research Coverage
29 May 2014 Appendix 3B - Issue of Unlisted Options
21 May 2014 Appendix 3Y - Stewart Washer
21 May 2014 Appendix 3Y - Ross Macdonald
18 May 2014 Vesting of Unlisted Options
12 May 2014 CYP to Participate in Major International Stem Cell Conference
04 Mar 2014 Cynata GvHD Partnership with University of Massachusetts
03 Mar 2014 Appendix 3Y - Stewart Washer
27 Feb 2014 Mr Howard Digby to Revert to Non-Executive Director Role
09 Feb 2014 Cynata Partners with Leading Biologic Product Manufacturer
20 Jan 2014 Appendix 3B - Exercise of Listed Options
15 Jan 2014 Experienced Stem Cell Product Developer to Join Cynata
19 Dec 2013 Appendix 3Y - Stewart Washer
18 Dec 2013 Appendix 3Y - Howard Digby
17 Dec 2013 Section 708A Notice
16 Dec 2013 Appendix 3B - Exercise of Listed Options
01 Dec 2013 Expiry of Unlisted Options
01 Dec 2013 Appendix 3Y - Peter Webse
28 Nov 2013 Notice of Ceasing to be Sustantial Shareholder x 4
26 Nov 2013 General Pre-Reinstatement Disclosure
26 Nov 2013 Updated Statement of Commitments.pdf
26 Nov 2013 Terms & Conditions of Options.pdf
26 Nov 2013 Restricted Securities.pdf
26 Nov 2013 Reinstatement to Official Quotation – 29 November.pdf
26 Nov 2013 Pre-Reinstatement Disclosure.pdf